MorphoSys

clock delay wait time alarm
Biotech

Novartis' $2.9B MorphoSys bet stumbles as safety delays filing

Novartis has revealed a safety signal that could set back plans to seek approval for the jewel of the acquisition by a couple of years.
Nick Paul Taylor Oct 29, 2024 6:16am
MA

Novartis only wanted pelabresib, but MorphoSys had other ideas

Apr 12, 2024 8:53am
merger MA unit combine consolidate deal

Novartis will pay €2.7B to pick up cancer specialist MorphoSys

Feb 5, 2024 7:06pm
Graphic of three faceless profiles aimed diagonally to the right with two check marks in between them Orange background

Third Rock adds 3 new venture partners, including Karuna’s Paul

Jan 25, 2024 10:35am
MorphoSys

MorphoSys fails secondary in blood cancer trial, sinking stock

Nov 21, 2023 5:52am
Graphic image of a rocket rising above six balloons that are at the same level

HI-Bio's expectations elevated by phase 2 autoimmune readouts

Apr 11, 2023 6:00am